ROSEN, A TOP LAW FIRM, Encourages Investors of AcelRx Pharmaceuticals, Inc. with Losses Over $ 100,000 to Obtain Legal Advice Before Important August 9th Deadline for Action collective securities agreement – ACRX | Company


NEW YORK – (BUSINESS WIRE) – August 2, 2021–

WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) between March 17, 2020 and February 12, 2021 inclusive (the “Period of appeal ‘), of the important August 9, 2021, lead applicant deadline.

SO WHAT: If you purchased AcelRx securities during the Class Period, you may be entitled to compensation without payment of fees or charges through a contingency fee agreement.

WHAT TO DO NEXT: To join the AcelRx class action lawsuit, go to or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action. A class action has already been filed. If you want to serve as the principal applicant, you must move the court no later than August 9, 2021. A principal plaintiff is a representative party acting on behalf of the other members of the class to direct the litigation.

WHY THE ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, the companies issuing reviews do not have significant experience, resources or recognition by their comparable peers. Be wise in choosing the right lawyer. Rosen law firm represents investors around the world, focusing its practice on class actions in securities and derivative litigation between shareholders. Rosen law firm has secured the largest securities class action settlement against a Chinese company. Rosen law firm was ranked # 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds millions of dollars for investors. In 2019 alone, the company raised more than $ 438 million for investors. In 2020, founding partner Laurence Rosen was appointed by law360 as the Titan of Plaintiffs’ Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, the defendants throughout the Class Period made false and / or misleading statements and / or failed to disclose that: (1) AcelRx had deficient disclosure controls and procedures with respect to its marketing of DSUVIA (the Company’s lead product candidate, a 30 mcg of sufentanil sublingual tablet for the treatment of moderate to severe acute pain); (2) as a result, AcelRx had made false or misleading statements and representations about the risks and effectiveness of DSUVIA in certain advertisements and displays; (3) the aforementioned conduct has subjected AcelRx to increased regulatory oversight and enforcement; and (4) accordingly, the defendants’ public statements were materially false and misleading at all material times. When the real details entered the market, the lawsuit claims that investors have suffered damage.

To join the AcelRx class action lawsuit, go to or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action.

No class has been certified. Until a group is certified, you are not represented by a lawyer unless you hire one. You can choose the board of your choice. You can also remain an absent group member and do nothing at this point. The ability of an investor to participate in any potential future recovery does not depend on whether he or she is a lead applicant.

Follow us for updates on LinkedIn:, on Twitter:— entreprise or on Facebook:

Lawyer advertising. Previous results do not guarantee a similar result.

See the source version on

CONTACT: Laurence Rosen, Esq.

Phillip Kim, Esq.

Rosen Law Firm, Pennsylvania

275 Madison Avenue, 40th Floor

New York, New York 10016

Phone. : (212) 686-1060

Toll free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]



SOURCE: Rosen Law Firm, Pennsylvania

Copyright Business Wire 2021.

PUB: 08/02/2021 22:24 / DISC: 08/02/2021 22:24

Copyright Business Wire 2021.

Source link

Leave A Reply

Your email address will not be published.